# TTA in Treatment of Diabetes and Dyslipidemia

> **NCT00605787** · PHASE2 · COMPLETED · sponsor: **Haukeland University Hospital** · enrollment: 16 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus
- Dyslipidemia

## Interventions

- **DRUG:** Tetradecylthioacetic acid (TTA)

## Key facts

- **NCT ID:** NCT00605787
- **Lead sponsor:** Haukeland University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** 2003-06
- **Final completion:** 2007-12
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2008-01-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00605787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00605787, "TTA in Treatment of Diabetes and Dyslipidemia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00605787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*